Pulmotect Has Developed Pul 042An Inhaled Therapeutic Which Aims To Boost The Body S Innate Immune System Resulting In Highly Targeted Lung Protection Against All Major Classes Of Pathogens Including Bacteriafungiand Viral Pathogens
No conferences found for this company.
| Company Name | Pulmotect Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.